Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCE-MRI assessment of bevacizumab with or without interferon alfa in advanced renal cell carcinoma
2008-006414-19Phase 2Terminated
- Sponsor
- East and North Hertfordshire NHS Trust
- Start
- Apr 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2 trial of bevacizumab in renal cell carcinoma (RCC) (2 arms), sponsored by East and North Hertfordshire NHS Trust. Started Apr 2009; status: terminated.
02
Drugs
bevacizumab
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on 2008-006414-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006414-19.